Results 141 to 150 of about 1,864,473 (295)

Insomnia and depression among bariatric surgery patients: the chain mediating effect of resilience and anxiety

open access: yesFrontiers in Psychiatry
ObjectiveThis study aimed to examine the psychological mechanisms of depression in both bariatric surgery candidates and post-bariatric surgery patients and to explore the roles of resilience and anxiety in these relationships.MethodsA total of 431 ...
Jijian Si   +5 more
doaj   +1 more source

Altered gut microbiome after bariatric surgery and its association with metabolic benefits: A systematic review.

open access: yes, 2019
Bariatric surgery is currently the recommended therapy for significant weight reduction and remission of type 2 diabetes. Different types of bariatric surgery result in dramatic changes to gut bacteria but the contribution of such changes to the ...
Murphy, Rinki   +3 more
core   +1 more source

Conservative Versus Operative Management of Small Bowel Obstruction in Pregnancy: An Updated Review of the Current Literature

open access: yesANZ Journal of Surgery, EarlyView.
Small bowel obstruction in pregnancy is rare but carries high maternal and foetal risk. Across 44 published cases, preterm delivery was 0% after successful conservative management, versus 53% operative and 75% failed conservative. A monitored conservative trial appears feasible in stable, selected patients, with early MRI and a true MDT.
Nesta Emily Baxter   +6 more
wiley   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

open access: yesBritish Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli   +7 more
wiley   +1 more source

Gut microbiota as a novel therapeutic target for eating disorders and obesity

open access: yesBritish Journal of Pharmacology, EarlyView.
The graphical abstract highlights the bidirectional interaction between the gut microbiota and central homeostatic and hedonic mechanisms regulating food intake, which contributes to overweight and obesity. It also illustrates emerging microbiota‐based biomarkers and therapeutic strategies (including prebiotics, probiotics, postbiotics, synbiotics and ...
Solveiga Samulėnaitė   +5 more
wiley   +1 more source

Re‐thinking peripheral dysfunctions in obesity: The emerging role of sulphaceutics and sulphanutraceutics

open access: yesBritish Journal of Pharmacology, EarlyView.
Obesity is a chronic, relapsing, multisystem disease in which cardiometabolic risk arises from excess adiposity and progressive dysfunction of peripheral organs, ultimately disrupting endocrine and metabolic crosstalk among tissues. Within this network, sulphur‐based biology, centred on hydrogen sulphide and related reactive sulphur species, has ...
Martina Smimmo   +4 more
wiley   +1 more source

Cost-utility and budget impact analysis of laparoscopic bariatric surgery for obesity with Type II Diabetes Mellitus in Thailand.

open access: yesPLoS ONE
Bariatric surgery is another treatment options for patients with obesity, who cannot achieve weight controlled by conservative non-surgical therapy. Although bariatric surgery provides clinical benefits for these patients, it is costly.
Prapaporn Noparatayaporn   +6 more
doaj   +1 more source

Bariatric Surgery and Metabolic Status

open access: yes
Background and Objectives: Obesity is associated with numerous co-morbidities, including dyslipidemia, insulin resistance and diabetes mellitus. Bariatric surgery is the mainstay of treatment for obesity as the only method with confirmed long-term ...
Anna Różańska-Walędziak   +5 more
core   +1 more source

Exploring individual experiences of preparedness for bariatic surgery [PDF]

open access: yes, 2012
Introduction: Obesity is associated with an increase in morbidity and mortality. Over the past 30 years the rate of obesity has been rising in almost all countries.
Noble, Rachael
core  

Effect of interdisciplinary obesity care on metabolic markers and body weight in people with type 2 diabetes in a rural setting: A randomised controlled trial

open access: yesClinical Obesity, Volume 15, Issue 2, April 2025.
Summary Management of type 2 diabetes includes medications that can unintentionally increase obesity and insulin resistance. This unblinded, single‐centre, randomised controlled trial focused on rural Australian adults with type 2 diabetes (aged 18–75 and body mass index [BMI] >30 kg/m2), measuring the effectiveness of a tailored interdisciplinary ...
Giuliana O. Murfet   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy